PubMed Users Now Save Time Accessing and Organizing Scientific Papers by Using Bibliogo from Reprints Desk

Santa Monica, Calif., February 2, 2011– Reprints Desk, Inc., a Derycz Scientific (OTC.BB:DYSC) company, today announced new PubMed citation and saved search importing features in Bibliogo, the journal article web app that helps users do more with scientific papers. Available freely to individual users who sign up at www.bibliogo.com, the latest Bibliogo features enable researchers to save time accessing full-text papers from PubMed and to improve the ways in which they manage and collaborate around scientific literature. 

Researchers click the new Bibliogo bookmarklet to push up to 100 PubMed references into Bibliogo’s multitasking engine, a kind of command central for price quotes, full-text paper acquisition and bibliography building. Actions are executed quickly on single references or across multiple references simultaneously without consuming any additional research time.

Researchers also use the bookmarklet to follow PubMed searches in Bibliogo. A single click inserts any PubMed search into Bibliogo’s monitoring and alerting system. Current and new results from PubMed searches, alongside references from table of contents subscriptions and other sources, surface to the top of each researcher’s Bibliogo feeds. Bibliogo then pushes alerts to researchers’ inboxes via email.

“Research scientists’ time is extremely valuable,” said Ian Palmer, Head of Marketing at Reprints Desk. “Productivity tools such as Bibliogo make research discovery much more efficient and have the potential to generate hundreds of thousands of dollars in soft cost time savings annually across a workforce.”

Reprints Desk expanded its single article document delivery and bulk article clinical reprints service features when it added Bibliogo to its Article Galaxy product platform in 2011. Bibliogo was named winner of the 2012 Best Online Science or Technology Service and a candidate for Best Collaboration/Social Networking Solution by the Software & Information Industry Association (SIIA) for their annual CODiE Awards. PubMed, a free Web service provided by the US National Library of Medicine (NLM), provides daily access to over 21 million biomedical citations for millions of users. 

To view a video tour of the newest Bibliogo features or to sign up for a free account and experience the breakthroughs made possible by Bibliogo, visit www.bibliogo.com. For more information about Reprints Desk, visit www.reprintsdesk.com.    

About Reprints Desk®
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions and scientific, technical, and medical (STM) research. Organizations based on intellectual property (IP) choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Outsell Inc., an independent analyst and advisory firm, ranked Reprints Desk #1 in the most recent Document Delivery Vendor Scorecard.

About Derycz Scientific®
Derycz Scientific, Inc. develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules.  Its subsidiary companies include Reprints Desk, Inc., Pools Press, Inc. and Techniques Appliquees aux Arts Graphiques, S.p.A. (TAAG).  For more information, please visit www.deryczscientific.com.

Forward-Looking Statements
Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K. The Company assumes no obligation to update the cautionary information in this release.